
News|Articles|November 24, 2025
Rethinking Clinical Trial Data in the Era of Decentralization
Author(s)Seriant
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
2
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
3
FDA Approves Yuvezzi to Treat Presbyopia in Adults
4
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
5